HLA Class II Polymorphism in Cystic Fibrosis: A Possible Modifier of Pulmonary Phenotype
Authors:
- 1 May 1999
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (5) , 1464-1468
Abstract
Evolution of lung damage is highly variable in cystic fibrosis (CF) even in patients with the same cystic fibrosis transmembrane conductance regulator (CFTR) mutations. The analysis of genetic factors other than CFTR may help our understanding of genotype–phenotype relationships in CF. As human leukocyte antigen (HLA) class II polymorphism has been associated with a number of diseases including autoimmune and inflammatory diseases, asthma, and allergy, we investigated the possibility that HLA polymorphism contributes to CF-associated pulmonary inflammation. Among the 98 adult CF patients tested, the genotypic frequencies of DR4 and DR7 alleles (serologic group DR53) and DR7/ DQA*0201 haplotype were higher than in 39 selected control subjects without atopy (p ≤ 10− 6, relative risk [RR] = 22, and p ≤ 5.10− 4, RR = 27, respectively) and in a random population. No significant difference of these allelic distributions was found according to the CFTR genotype. In the CF patients, the DR7 allele was significantly associated with an increase in total IgE and with chronic Pseudomonas aeruginosa colonization (100% of DR7 versus 83% of non-DR7 patients being colonized, p < 0.05). Our results suggest that genetic factors known to modulate the immune response might contribute to chronic infection with Pseudomonas, increased total IgE, and pulmonary outcome in CF.Keywords
This publication has 25 references indexed in Scilit:
- Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factorNature Genetics, 1996
- Allergy to olive pollen: T-cell response from olive allergic patients is restricted by DR7-DQ2 antigensClinical & Experimental Allergy, 1996
- HLA class II haplotype in atopic asthmatic and non‐atopic control subjectsClinical & Experimental Allergy, 1995
- A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells.Allergy, 1994
- Association between IgE response against Bet v I, the major allergen of Birch Pollen, and HLA-DRB allelesHuman Immunology, 1992
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989
- The class II molecules of the human and murine major histocompatibility complexCell, 1984
- Pseudomonas infection, allergy, and cystic fibrosis.Archives of Disease in Childhood, 1982
- Cystic Fibrosis and HLATissue Antigens, 1978
- Immunological studies in cystic fibrosisArchives of Disease in Childhood, 1978